reiterateAXGNfinnhub
HC Wainwright & Co. Reiterates Buy Rating on AxoGen, Inc. (AXGN)
Rating Change HC Wainwright & Co. analysts reiterated a Buy rating on AxoGen, Inc. (NASDAQ:AXGN) on July 30, 2026.
Read moreFeatured By
Real-time context
Upgrades, downgrades, initiations, and price-target changes.
Rating Change HC Wainwright & Co. analysts reiterated a Buy rating on AxoGen, Inc. (NASDAQ:AXGN) on July 30, 2026.
Read moreRating Change Citizens analysts reiterated a Market Outperform rating on AxoGen, Inc. (NASDAQ:AXGN) on July 30, 2026. Market Context AxoGen, Inc.
Read moreRating Change Canaccord Genuity analysts reiterated a Buy rating on AxoGen, Inc. (NASDAQ:AXGN) on July 30, 2026. Market Context AxoGen, Inc.
Read moreRating Change Barclays analysts reiterated a Equal-Weight rating on Fortrea Holdings Inc. (NASDAQ:FTRE) on July 30, 2026. Market Context Fortrea Holdings Inc.
Read moreRating Change Evercore ISI Group analysts reiterated a Outperform rating on Fortrea Holdings Inc. (NASDAQ:FTRE) on July 30, 2026. Market Context Fortrea Holdings Inc.
Read moreRating Change Truist Securities analysts reiterated a Buy rating on Fortrea Holdings Inc. (NASDAQ:FTRE) on July 30, 2026. Market Context Fortrea Holdings Inc.
Read moreRating Change Needham analysts reiterated a Buy rating on Stagwell Inc. (NASDAQ:STGW) on July 30, 2026. Market Context Stagwell Inc.
Read moreRating Change Keefe, Bruyette & Woods analysts reiterated a Market Perform rating on German American Bancorp, Inc. (NASDAQ:GABC) on July 30, 2026. Market Context German American…
Read moreRating Change Piper Sandler analysts reiterated a Overweight rating on German American Bancorp, Inc. (NASDAQ:GABC) on July 30, 2026. Market Context German American Bancorp, Inc.
Read moreRating Change Argus Research analysts reiterated a Buy rating on The Cheesecake Factory Incorporated (NASDAQ:CAKE) on July 30, 2026. Market Context The Cheesecake Factory…
Read moreRating Change BTIG analysts reiterated a Buy rating on Adaptive Biotechnologies Corporation (NASDAQ:ADPT) on July 30, 2026. Market Context Adaptive Biotechnologies Corporation…
Read moreRating Change Guggenheim analysts reiterated a Buy rating on Adaptive Biotechnologies Corporation (NASDAQ:ADPT) on July 30, 2026. Market Context Adaptive Biotechnologies…
Read moreRating Change Morgan Stanley analysts reiterated a Equal-Weight rating on Adaptive Biotechnologies Corporation (NASDAQ:ADPT) on July 30, 2026. Market Context Adaptive…
Read moreRating Change TD Cowen analysts reiterated a Buy rating on Adaptive Biotechnologies Corporation (NASDAQ:ADPT) on July 30, 2026. Market Context Adaptive Biotechnologies Corporation…
Read moreRating Change Piper Sandler analysts reiterated a Neutral rating on Trustmark Corporation (NASDAQ:TRMK) on July 30, 2026. Market Context Trustmark Corporation operates in the…
Read moreRating Change DA Davidson analysts reiterated a Neutral rating on Trustmark Corporation (NASDAQ:TRMK) on July 30, 2026. Market Context Trustmark Corporation operates in the…
Read moreRating Change Wells Fargo analysts reiterated a Overweight rating on Constellium SE (NYSE:CSTM) on July 30, 2026. Market Context Constellium SE operates in the Basic Materials…
Read moreRating Change BMO Capital analysts downgraded Neptune Insurance Holdings Inc. (NYSE:NP) from Outperform to Market Perform on July 30, 2026. Market Context Neptune Insurance…
Read moreRating Change Keefe, Bruyette & Woods analysts reiterated a Market Perform rating on Park National Corporation (AMEX:PRK) on July 30, 2026. Market Context Park National…
Read moreRating Change Canaccord Genuity analysts reiterated a Buy rating on Inter Parfums, Inc. (NASDAQ:IPAR) on July 30, 2026. Market Context Inter Parfums, Inc.
Read more